44 Cook Street Suite #100
Denver, CO 80206
Foundation
Mission
The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code. The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.
Need
Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.
Solution
Cardiovascular Innovations annual meeting provides an educational forum for health care practitioners to learn the newest innovation in the delivery of cardiovascular care. Through educational tracks and lectures designed to identify the benefits of endovascular, surgical, and medical therapy, attendees are able select appropriate patients for vascular revascularization and utilize more advanced techniques to treat complex disease such as carotid stenosis, acute DVT, pulmonary embolism, PAD, and CLI.
Board of Directors
Subash Banerjee
MD, FACC, FSCAI
Paul J. Thomas Endowed Chair, Chief of Cardiovascular Research & Innovation,
Baylor Heart and Vascular Hospital, Dallas, TX
Emmanouil S. Brilakis
MD, PhD, FACC, FAHA, FSCAI, FESC
Director – Center for Complex Coronary Interventions Minneapolis Heart Institute at Abbott Northwestern Hospital
Mehdi H. Shishehbor
DO, MPH, PhD, FACC, FAHA, FSCAI
President, University Hospitals Harrington Heart & Vascular Institute
Professor of Medicine, Case Western Reserve University School of Medicine
The Angela and James Hambrick Chair in Innovation, University Hospitals, Cleveland, Ohio
Paul Sorajja
MD, FACC, FAHA, FSCAI
Director – Center for Valve and Structural Heart Disease Minneapolis Heart Institute at Abbott Northwestern Hospital
Director – Valve Science Center Minneapolis Heart Institute Foundation
Executive Committee
Khaldoon Alaswad, MD
Director – Cardiac Catheterization Laboratory Edith and Benson Ford Heart and Vascular Institute
Henry Ford Hospital Henry Ford Health System
Clinical Assistant Professor of Medicine Wayne State University
Philippe Généreux, MD
Medical Director – Structural Heart Program
Gagnon Cardiovascular Institute, Morristown Medical Center, NJ
Allison Hall, MD
Interventional Cardiologist/Cardiologist
Co-Director – CTO/CHIP Program
Clinical Assistant Professor of Medicine – Eastern Health/Memorial University of Newfoundland
Nadira Hamid, MD
Interventional Echocardiography
Valve Science Center, Minneapolis Heart Institute Foundation
Abbott Northwestern Hospital
Jun Li, MD
Endovascular Interventional Cardiology – University Hospitals Harrington Heart & Vascular Institute
Assistant Professor of Medicine – Case Western Reserve University School of Medicine
Shirling Tsai, MD
Program Director – Vascular Surgery Fellowship and Integrated Residency Programs
Department of Surgery – Division of Vascular Surgery, Dallas VA Medical Center
UT Southwestern Medical Center
